US Stocks
/
Pyxis Oncology, Inc. Share Price

Pyxis Oncology, Inc. Share Price

NASDAQ: PYXS | Micro Cap
$2.05
+$0.06 (3.27%) Last updated on 09 Oct, 2026 | 22:11 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Pyxis Oncology, Inc. Stock Performance

Open
$2.02
Prev. Close
$1.99
Circuit Range
N/A
Day Range
$1.99 - $2.06
Year Range
$1.03 - $5.55
Volume
19,847
Average Traded
$2.02

Pyxis Oncology, Inc. Share Price Today

As of 9 October 2026, Pyxis Oncology, Inc.'s share price is $2.05. The stock opened at $2.02, compared to its previous close of $1.99. During today's trading session, Pyxis Oncology, Inc.'s share price traded between $1.99 and $2.06, with an average price of $2.02. Over the past 52 weeks, the stock has recorded a high of $5.55 and a low of $1.03. In terms of performance, Pyxis Oncology, Inc.'s share price has risen by 20.23% over the last six months and is down 42.66% on a year-on-year basis.

Pyxis Oncology, Inc. Share Price Chart

$1.99$2.06
L
Show Current Price
H

Pyxis Oncology, Inc. Stock Fundamentals & Key Indicators

Market Cap
$127.39M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.06
Revenue (TTM)
$13.86B
Return On Equity (TTM)
-775.59%
Profit Margin
-574.46%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-15.23%

Pyxis Oncology, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$11.04$0.00$0.00
Net Profit-$22.00-$18.11-$23.27-$25.35
Net Profit MarginN/A-164.04%N/AN/A
Income ChangeN/A17.68%-28.49%-8.94%

Pyxis Oncology, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$16.15$13.86
Net Profit-$120.72-$73.79-$77.33-$79.62
Net Profit MarginN/AN/A-478.82%-574.46%
Income ChangeN/A38.88%-4.80%-2.96%

About Pyxis Oncology, Inc.

Pyxis Oncology Inc is a clinical-stage oncology company focused on developing therapies for patients with solid tumors, with an initial emphasis on head and neck squamous cell carcinoma. Its product candidate, micvotabart pelidotin (MICVO, formerly PYX-201), is an investigational antibody-drug conjugate that targets extradomain-B fibronectin (EDB+FN), a component of the tumor extracellular matrix that is expressed in tumors and minimally present in normal tissues. MICVO consists of a fully human monoclonal antibody linked to a microtubule inhibitor payload, designed to bind within the tumor microenvironment and release its payload to kill cancer cells directly, affect nearby cells through a bystander effect, and induce immunogenic cell death, supporting enhanced anti-tumor activity.

Pyxis Oncology, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$2.27
$2.04
-12.07%
Sep 2026
$3.27
$2.32
-30.54%
Aug 2026
$2.79
$3.34
+26.52%
Jul 2026
$3.06
$2.64
-12.00%
Jun 2026
$1.81
$3.00
+66.20%
May 2026
$1.69
$1.80
+5.87%
Apr 2026
$1.52
$1.71
+16.78%
Mar 2026
$1.40
$1.46
-1.02%
Feb 2026
$1.49
$1.48
+1.03%
Jan 2026
$1.14
$1.46
+26.41%
Dec 2025
$5.10
$1.16
-77.66%
Nov 2025
$3.65
$5.17
+44.62%

PYXS Share Price FAQs

What is Pyxis Oncology, Inc. share price today?

chevron-up
Pyxis Oncology, Inc. share price today is $2.05 as on October 9, 2026 at 10:11 pm IST.

What is the 52 week high and 52 week low of Pyxis Oncology, Inc. stock?

chevron-up
The 52 week high of Pyxis Oncology, Inc. stock is $5.55, while the 52 week low is $1.03 as of 9 Oct '26.

What is PYXS's market capitalisation today?

chevron-up
PYXS market capitalisation is $127.39M as of October 9, 2026, at 10:16 pm IST.

What is PYXS's net income for the last quarter?

chevron-up
PYXS's net income for the last quarter is -25.35B USD.

What is the 5 year returns of PYXS?

chevron-up
The 5 year returns of PYXS is -84.63% as on 9 Oct '26.

What is the high & low stock price of PYXS today?

chevron-up
PYXS stock price hit a high of $2.06 and low of $1.99 as of 9 Oct '26.

Can I buy PYXS shares in India?

chevron-up
Yes. You can buy PYXS in India by opening an international trading account.